Chronic Stable Heart Failure
11
0
0
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
9.1%
1 terminated out of 11 trials
85.7%
-0.8% vs benchmark
45%
5 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Enhancing Cardiac Rehabilitation Through Behavioral Nudges
Qishenyiqi for Ventricular Remodeling After Myocardial Infarction
Efficacy and Safety of TRC041266 in Patients With Heart Failure, LVEF ≥40%, Diastolic Dysfunction and Type 2 Diabetes Mellitus
Noninvasive Ventilation for Chronic Heart Failure
A Study of CLR325 in Chronic Stable Heart Failure Patients.
Text Message Intervention to Improve Cardiac Rehab Participation
Cardiac Rehabilitation Peer Mentorship
Matrix Metalloproteinase (MMP) in Heart Failure
Efficacy and Safety of Pulsed Infusions of Levosimendan in Outpatients With Advanced Heart Failure
Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF)
Effects of Spironolactone on Matrix Metalloproteinases (MMPs) in Heart Failure